Y200-1307 Screening compound: 3-bromo-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]benzamide

Y200-1307 Screening compound: 3-bromo-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]benzamide
Y200-1307 Screening compound: 3-bromo-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-1307
3-bromo-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-1307

Molecular Formula

C16H10BrFN2OS (C16 H10 BrFN2 OS)

Compound Name

3-bromo-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]benzamide

IUPAC name

3-bromo-N-[4-(4-fluorophenyl)-13-thiazol-2-yl]benzamide

SMILES

O=C(c1cccc(Br)c1)Nc1nc(-c(cc2)ccc2F)cs1

InChI

InChI=1S/C16H10BrFN2OS/c17-12-3-1-2-11(8-12)15(21)20-16-19-14(9-22-16)10-4-6-13(18)7-5-10/h1-9H,(H,19,20,21)

InChI Key

QNIXSKQGAQGNQT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00299935

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

377.24

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

5.516

Distribution Coefficient, logD

5.511

Water Solubility, LogSw

-6.00

Polar Surface Area

33.104

Acid Dissociation Constant (pKa)

9.34

Base Dissociation Constant (pKb)

-1.03

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y200-1307 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

Anticancer Library (62698 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
  • Proteases
  • Ion Channels
Mechanism of action:
  • Epigenetic
  • Epigenetic

References: we are preparing a list of scientific research reports with Y200-1307 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-1307?
Check Price and Availability of Y200-1307, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-1307 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-1307
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-1307
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-1307 available by request